IL147097A0 - Methods of imaging and targeting tumor vasculature - Google Patents

Methods of imaging and targeting tumor vasculature

Info

Publication number
IL147097A0
IL147097A0 IL14709700A IL14709700A IL147097A0 IL 147097 A0 IL147097 A0 IL 147097A0 IL 14709700 A IL14709700 A IL 14709700A IL 14709700 A IL14709700 A IL 14709700A IL 147097 A0 IL147097 A0 IL 147097A0
Authority
IL
Israel
Prior art keywords
imaging
methods
tumor vasculature
targeting tumor
targeting
Prior art date
Application number
IL14709700A
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of IL147097A0 publication Critical patent/IL147097A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
IL14709700A 1999-06-17 2000-06-08 Methods of imaging and targeting tumor vasculature IL147097A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13964299P 1999-06-17 1999-06-17
PCT/US2000/015732 WO2000078361A2 (en) 1999-06-17 2000-06-08 Methods of imaging and targeting tumor vasculature

Publications (1)

Publication Number Publication Date
IL147097A0 true IL147097A0 (en) 2002-08-14

Family

ID=22487626

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14709700A IL147097A0 (en) 1999-06-17 2000-06-08 Methods of imaging and targeting tumor vasculature

Country Status (7)

Country Link
EP (1) EP1185307A2 (en)
JP (1) JP2003502391A (en)
AU (1) AU5472200A (en)
CA (1) CA2377188A1 (en)
HK (1) HK1043314A1 (en)
IL (1) IL147097A0 (en)
WO (1) WO2000078361A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030118585A1 (en) 2001-10-17 2003-06-26 Agy Therapeutics Use of protein biomolecular targets in the treatment and visualization of brain tumors
US20030165263A1 (en) 2002-02-19 2003-09-04 Hamer Michael J. Histological assessment
TWI445525B (en) 2004-06-02 2014-07-21 Sidney Kimmel Cancer Ct Use of vascular targets for detecting, imaging and treating neoplasia or neovasculature
US8815235B2 (en) 2004-06-02 2014-08-26 Jan E. Schnitzer Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU757554B2 (en) * 1998-02-11 2003-02-27 Bracco International B.V. Angiogenesis targeting molecules
DE19845798A1 (en) * 1998-09-29 2000-04-13 Schering Ag Use of neoangiogenesis markers for diagnosis and therapy of tumors, agents containing them, and methods for their production

Also Published As

Publication number Publication date
CA2377188A1 (en) 2000-12-28
JP2003502391A (en) 2003-01-21
WO2000078361A3 (en) 2001-08-09
AU5472200A (en) 2001-01-09
EP1185307A2 (en) 2002-03-13
WO2000078361A2 (en) 2000-12-28
HK1043314A1 (en) 2002-09-13

Similar Documents

Publication Publication Date Title
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
GB9903841D0 (en) Diagnosis and treatment of cancer
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
EP1418843A4 (en) Device for palpation and mechanical imaging of the prostate
HUP0201757A3 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
EP1183030A4 (en) Methods of making and using n-desmethylzopiclone
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU2002243623A1 (en) Methods of imaging and targeting vasculature
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
IL144845A0 (en) Vaccines and gene therapy compositions and methods of making and using the same
AU7817500A (en) Method of tumor imaging
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
IL147097A0 (en) Methods of imaging and targeting tumor vasculature
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
IL161332A0 (en) Pacap compositions and methods for tumor imaging and therapy
EP1173189A4 (en) Asialocytokines and treatment of liver disease
GB9812550D0 (en) Tumour therapy and imaging
IL132531A0 (en) Detection and therapy of tumors